Gestational diabetes mellitus (GDM) is common all over the world. GDM women are with inflammatory and metabolisms abnormalities. However, few studies have focused on the association of IL-65-72C/G and TNF-a -857C/T single nucleotide polymorphisms (SNPs), inflammatory biomarkers, and metabolic indexes in women with GDM, especially in the Inner Mongolia population. The aim of this study was to investigate the associations of IL-65-72C/G and TNF-a -857C/T SNPs, and inflammation and metabolic biomarkers in women with GDM pregnancies.
Background
Gestational diabetes mellitus (GDM) is a common endocrine and metabolic disease with different degrees of glucose and lipid metabolic disorders during pregnancy, causing danger to the mothers and the perinatal infants, and can even be lifethreatening [1, 2] . However, the pathogenesis of GDM is still unclear, and might be related to hormone level changes, insulin resistance (IR), obesity, a chronic inflammatory reaction, oxidative stress, genetics, insulin-secretion deficiency, immunity and so on [3] .
Recently attention has focused on the relationship between inflammatory reaction and IR, indicating that inflammation is a critical factor in promoting IR. During pregnancy, the maternal tissues become insensitive to insulin resulting from changes due to placental lactogen and other hormones. For women with GDM, IR results in maternal hyperglycemia and stimulates fetal hyperinsulinemia [4] . IR and reduced secretory function of b cell are important pathological features of GDM.
After giving birth, GDM in women disappears immediately. Risk factors, such as increased maternal age, previous occurrence of GDM, and family history of diabetes, are helpful for diagnosis of GDM [5] .
In China, a universal screening program for GDM in women living in the six urban districts of Tianjin was carried out, with the results showing that the GDM prevalence was as low as 2.3% in 1998 [6] . However, there is scant research on the prevalence of GDM in the Chinese population, and in particular Inner Mongolia.
In our study, we analyzed the expressions of IL-65-72C/G and TNF-a -857C/T SNPs in GDM patients from Inner Mongolia, as well as their relationship with glucose and lipid metabolism, in order to inform clinical diagnosis and prevention of GDM with information on related molecular mechanisms. GDM pregnancies were diagnosed according to the criteria of Endocrine Society Clinical Practice Guideline [7] and American College of Obstetricians and Gynecologists (ACOG). The pregnant women, with gestational weeks of 24~28, were screened for GDM by one hour 50 g glucose challenge test (GCT). When the fasting glucose was higher than 92 mg/d/L but lower than 126 mg/d/L, GDM was diagnosed at any gestational age. Those pregnant women in early pregnancy, not meeting the diagnostic criteria for GDM, were asked to have oral glucose tolerance test (OGTT) from the 24 th and 28 th gestational weeks [7] .
Material and Methods

Patients
Genomic DNA extraction and polymerase chain reaction (PCR)
We collected 10 mL peripheral blood at 9: 00 in the morning, which was then store at -28°C for subsequent experiments. A sample of 2 mL of the blood was used for SNPs analysis. Genomic DNA in each sample was extracted and purified with genomic DNA extraction kit (Thermo Fisher Scientific, Inc., Shanghai, China) according to the kit specification, and then stored at -78°C until PCR amplification.
PCR primers were designed with Sequenom Assay Desigh 3.0 software and synthesized by Thermo Fisher. Primers are shown in Table 1 . DNA samples were diluted quantitatively and then prepared for amplification. PCR amplification system is shown in Table 2 , with the process in Table 3 . After amplification, 0.3 U alkaline phosphatase was added to remove the remaining Table 1 . Primers for amplification on IL-6-572C/G and TNF-a -857C/T.
IL-6 -interleukin-6; TNF-a -tumor necrosis factor-a; F -forward primer; R -reverse primer. deoxyribonucleotide triphosphate (dNTP). Finally the PCR products were spotted into SpectroCHIP (Sequenom) with the automatic instrument. MALDI-TOF-MS (SpectroREADER, Sequenom) was used to detect the chips.
Metabolic and inflammatory biomarkers
High sensitivity C-reactive protein (hs-CRP), fasting blood glucose (FBG), and fasting blood insulin (FINS) were detected by automatic biochemical analyzer (BioTek Instrument, Inc., Beijing, China). Homeostasis Model Assessment (HOMA) formula was used for calculating IR index (HOMA-IR) and islet b cell function index (HOMA-b). Serum Interleukin-1b (IL-1b), IL-6, IL-8, IL-10, and tumor necrosis factor-a (TNF-a) were determined by BioPlex 200 Systems with Bio-Plex ProTM Human Cytokine Assay kits (Bio-Rad Laboratories, Inc., Shanghai, China).
Placental tissues
Fresh placental tissues were collected after delivery and fixed in 10% formalin (Solarbio Technology Co., Ltd., Beijing. China), and then finely ground with RIPA buffer (Thermo). Tissue residues were discarded after centrifuging. Tissue suspension was used for detecting placental indexes by enzyme linked immunosorbent assay (ELISA), including nuclear factor-kB (NF-kB), TNF-a, IL-1b, IL-6, IL-8, IL-10, leptin, adiponectin, visfatin, retinol-bind- Table 2 . PCR amplification system for IL-6-572C/G and TNF-a -857C/T.
PCR -polymerase chain reaction; IL-6 -interleukin-6; TNF-a -tumor necrosis factor-a; dNTP -deoxyribonucleotide triphosphate.
Step Table 3 . PCR amplification conditions for IL-6-572C/G and TNF-a -857C/T.
PCR -polymerase chain reaction; IL-6 -interleukin-6; TNF-a -tumor necrosis factor-a. 
Results
IL-65-72C/G and TNF-a -857C/T
Mass spectrometry of IL-65-72C/G and TNF-a -857C/T genotypes are shown in Figure 1 and As shown in Figure 1A and 1B, there were 20 samples of GDM pregnancies and healthy pregnancies without results. The distribution frequencies of IL-65-72C/G in GDM pregnancies were: CC (19.29%), CG (54.29%), and GG (26.43%). The allele frequencies were C (46.43%) and G (53.57%), respectively. In healthy pregnancies, IL-65-72C/G frequencies were CC (21.67%), CG (37.50%), and GG (40.83%), and the allele frequencies were C (40.42%) and G (59.58%). There was no significant difference on genotypes or allele frequencies of IL-65-72C/G between GDM and healthy pregnancies.
As shown in Figure 1C and 1D, there were six samples of GDM pregnancies and 16 of healthy pregnancies without results. The distribution frequencies of TNF-a -857C/T in GDM were Table 4 . Distribution of IL-6-572C/G and TNF-a -857C/T polymorphism in GDM and healthy pregnancies.
IL-6 -interluekin-6; GDM -gestational diabetes mellitus; OR -odd ratio; CI -confidence interval. Table 5 . Comparisons on clinical characteristics, serum metabolic indexes and inflammatory biomarkers of the pregnancies with or without GDM (X ±SD) (N=120).
GDM (n=60) Control (n=60) P
GDM -gestational diabetes mellitus; BMI -body mass index; T2DM -type 2 diabetes mellitus; hs-CRP -high sensitivity C-reactive protein; IL -interleukin; TNF-a -tumor necrosis factor-a; FBG -fasting blood glucose; FINS -fasting blood insulin; HOMA -homeostasis model assessment; IR -insulin resistance; X±SD -mean ± standard deviations; * P<0.05. CC (72.86%) and CT (22.86%), and allele frequencies were C (88.06%) and T (13.56%). In healthy pregnancies, the distribution frequencies of TNF-a -857C/T were CC (77.86%) and CT (10.71%), and the allele frequencies were C (93.95%) and T (6.05%), respectively. The differences of the two genotypes frequencies were statistically significant between GDM and healthy pregnancies (chi-square=5.84, p<0.05), as well as the allele frequencies (chi-square=6.97, p<0.05). The distribution frequency of CT in GDM pregnancies was significantly higher than in healthy pregnancies (OR=3.316, 95% CI=1.092-8.304, p=0.025), which showed that the risk of developing GDM for patients carrying CT genotype.
Clinical characteristics, serum metabolic and inflammatory biomarkers (A) Serum inflammatory factors; (B) placental inflammatory factors and adipokines, * p<0.05). GDM -gestational diabetes mellitus; hs-CRP -high sensitivity C-reactive protein; IL -interleukin; TNF-a -tumor necrosis factor-a; NF-kB -nuclear factor-kB; RBP -retinol-binding protein; irs-1 -insulin receptor substrate-1; FATP -fatty acid transport protein; ELendothelial lipase; LPL -low density lipoprotein; FABP -fatty acid binding protein.
Association of serum inflammatory biomarkers with GDM
As shown in Table 6 , some of the serum inflammatory biomarkers were obviously associated with GDM, including CRP (0R=9. 
Inflammatory biomarkers and adipokines in placentas
After delivery, inflammatory biomarkers and adipokines in placentas were detected and compared. The results are shown in Table 7 .
In Figure 2B , except for IL-10, all the inflammatory biomarkers in placentas had significant differences (p<0.05) between GDM pregnancies and healthy pregnancies, 
Discussion
In our study, we firstly detected the SNPs of IL-65-72C/G and TNF-a -857C/T in GDM and healthy pregnancies. The results showed that the differences in the CC and CT genotypes of TNF-a -857C/T were statistically significant between GDM and healthy pregnancies, while IL-65-72C/G was without significance. The distribution frequency of TNF-a -857CT in GDM pregnancies was higher than that in healthy pregnancies, which indicated a risk of developing GDM for patients carrying TNF-a -857CT, and T allele was the risk factor.
According to previous studies, IL-65-72C/G is associated to obesity [8, 9] , colon cancer [10] , and T2DM [11] ; as is TNF-a -857C/T [7, 8] , but no research has focused on their relationship with GDM. In our study, we did not find an association of IL-65-72C/G with GDM pregnancies. Therefore, we presumed that women carrying TNF-a -857CT in Inner Mongolia were at higher risk for GDM than those without.
In addition, by detecting serum factors we found that hs-CRP, IL-6, IL-8, and IL-6/IL-10 were significantly associated with GDM. The inflammatory cytokines TNF-a [12] , IL-6 [13, 14] , hs-CRP [14, 15] , IL-1 b [16, 17] , and IL-8 [18] have mostly been found to be increased in GDM pregnancies compared to healthy pregnancies. However, in our study, TNF-a and IL-1b was found to be abnormal in GDM pregnancies, but not significantly. This difference might be due to differences in pregnancies within different population, indicating that for GDM women in Inner Mongolia, abnormal levels of hs-CRP, IL-6, IL-8, and IL-6/IL-10 ratio may be diagnostic biomarkers.
In women with GDM, the placenta may adapt to the inflammatory environment and exhibit morphological changes [19] [20] [21] .
In our study, we collected the placentas from GDM and healthy pregnancies. By detecting the metabolic indexes, we found that the inflammatory biomarkers, including NF-kB, IL-6, IL-8, Table 6 . Association of serum inflammatory biomarkers with GDM (X ±SD).
GDM -gestational diabetes mellitus; CRP -C-reactive protein; IL -interleukin; TNF-a -tumor necrosis factor-a; X ±SD -mean ± standard deviations; * P<0.05.
IL6/IL-10 ratio, IL-1b, and TNF-a, had significant differences between GDM and healthy pregnancies, as well as the adipokines, including leptin, adiponectin, visfatin, RBP-4, chemerin and nesfatin-1, IRS-1, IRS-2, FATP-4, EL, LPL, FABP-1, FABP-3, FABP-4, and FABP-5. This phenomenon showed that the placentas of GDM women were in an inflammatory environment, and that the increased inflammatory mediators might promote intraplacental inflammatory cascades by specific gene transcription or translation. Additionally, the adipose tissue also generated numbers of adipokines to promote the production of inflammatory cytokines, which aggravated the GDM status.
Otherwise, we found that both FBG and FINS in serum obviously increased, and the HOMA-IR and HOMA-b were significantly different between GDM and healthy pregnancies. Considering the decreased IRS-1 and IRS-2 in placentas of GDM, we confirmed 
